原发性脑肿瘤单纯放疗未导致循环淋巴细胞减少
结果未观察到放疗引起的总淋巴细胞计数或其亚群显著变化,剂量学分析显示总血液剂量约0.1至0.2 Gy且头颈部多数淋巴结受照较少,质子放疗对血液和淋巴结的剂量保护更优。
要点
- 原发性脑肿瘤单纯放疗未引起外周淋巴细胞计数或其亚群显著变化。
- 总血液剂量约0.1至0.2 Gy,头颈部多数淋巴结受照较少。
- 质子放疗较光子放疗对血液和淋巴结的剂量保护更优。
核心结论
- 探索性分析未发现单纯放疗导致接受限制性颅内照射的原发性脑肿瘤患者外周淋巴细胞计数显著变化。
- 无明显放疗诱导的细胞毒性与血液及区域淋巴结所受有限剂量一致。
研究设计与样本
- 仅纳入未接受同步化疗的患者,接受光子或质子放疗。
- 放疗前、中、后及首次随访采集血样行流式细胞分析,并用随机模型结合患者特异性血流模拟计算血液剂量分布,同时评估头颈部淋巴结剂量。
主要发现
- 该队列中放疗未引起总淋巴细胞计数或其亚群显著变化。
- 剂量学分析显示总血液剂量约0.1至0.2 Gy,头颈部大多数淋巴结受照较少。
- 质子放疗与血液和淋巴结的更大剂量保护相关。
关键数值与推荐
- 总血液剂量约0.1至0.2 Gy。
- 头颈部大多数淋巴结受照较少。
临床怎么用
- 对接受限制性颅内容积放疗的原发性脑肿瘤患者,单纯放疗可能不会显著降低外周淋巴细胞计数。
- 质子放疗可能进一步减少血液和头颈部淋巴结剂量,但需结合个体情况评估。
局限性
- 仅纳入未接受同步化疗的患者。
- 未报告淋巴细胞亚群的具体数值及统计检验细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the impact of radiation therapy (RT) for brain tumors on circulating lymphocyte populations and understand this from a dosimetric perspective. METHODS AND MATERIALS: This prospective study enrolled patients with primary brain tumors treated with either photon or proton RT. To specifically study the effect of RT, only patients without concurrent chemotherapy were eligible. For each patient, blood samples were collected before, during, and after RT, as well as at the first follow-up, for flow cytometry analysis of blood cells. We used a stochastic model to compute blood dose distributions from treatment plans and patient-specific blood flow simulations. Dose to the lymph nodes (LNs) in the head and neck region was also assessed. Dose distributions and lymphocyte trends from patients treated with photon versus proton therapy were compared. RESULTS: Thirty-five patients with a median age of 50 were included: 27 patients with benign tumors (mostly meningiomas) and 8 with malignant tumors (mostly gliomas). There were no significant RT-induced changes in either the total lymphocyte count or its subpopulations in this patient cohort. In line with this finding, dosimetric analyses showed that total blood doses were ∼0.1 to 0.2 Gy and that most LNs in the head and neck area are spared. Proton RT was associated with a greater dosimetric sparing of both blood and LNs. CONCLUSIONS: In this exploratory analysis, we found no evidence that RT alone results in significant changes in peripheral lymphocyte counts in patients with primary brain tumors treated to limited intracranial volumes. The lack of apparent RT-induced cytotoxicity is consistent with the limited dose received by either the blood or the regional LNs.
引用
- Beekman C, Morita S, Neibart S, et al. No Evidence for Depletion of Circulating Lymphocyte Populations in Primary Brain Tumor Patients Receiving Radiation Therapy Alone. Int J Radiat Oncol Biol Phys. 2026. PMID: 42315079. doi:10.1016/j.ijrobp.2026.05.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。